MentionFox
Home › funding signals › NewcelX Ltd.
Form D · on the record

NewcelX Ltd. — $2.88M Form D filing, November 2026

Before you sell to, join or invest in NewcelX Ltd.

MentionFox check on NewcelX Ltd.: only 1 source on file so far (checked 19 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/newcelx-ltd-form-d-121840

Check NewcelX Ltd. before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about NewcelX Ltd.?

NewcelX Ltd. filed a Form D with the Securities and Exchange Commission on 2026-11-18.

NewcelX Ltd. filed a Form D notice of an exempt securities offering with the SEC on November 18, 2026. NewcelX Ltd. trades on Nasdaq as NCEL; it was formerly NLS Pharmaceutics Ltd. The filing reports $2.88M sold. Its industry group is Biotechnology. It names Ronen Twito (Executive Chairman and Chief Executive Officer), Michel Revel (Executive Officer, Director), Kfir Molakandov (Executive Officer) (SEC Form D, November 18, 2026).

Sell to companies like NewcelX Ltd? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

NewcelX Ltd. raised on Nov 18. 137 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Linework USA INC.$1.2BAI and software
Linework USA INC.$326MAI and software
Pathos AI, Inc.$238MBiotech
Galvanize Therapeutics, Inc.$136MBiotech
Tractian Inc.$106MAI and software
Check one company free All companies that raised this week

5 more Biotechnology raises within 90 days of this one ↓

Selling to NewcelX Ltd.? See who runs it and how to reach them, plus this week's 161 other newly funded companies.

Is this your company?

Key facts

Run the free check on NewcelX Ltd. →

NewcelX Ltd.

New Form D on file · 2026-11-18 · the record

$2.88M
raise on the record
D
filing
5
investors in
SWITZERLAND
based
Open the record →

What the record says

FilingForm D
Filed2026-11-18
Industry groupBiotechnology
Entity typeOther
Incorporated inSWITZERLAND
BasedKLOTEN, SWITZERLAND
CIK1783036
Accession0001213900-26-121840

Pitching, partnering or investing alongside them? See who really runs and owns NewcelX Ltd.

Free to see. No signup.

Keep reading

More on the people and the money behind NewcelX Ltd., from the filings we hold.

More raises like this

Biotechnology raises filed within 90 days of this one, largest first.

What do you want to do with NewcelX Ltd.?

Get the full cited report on NewcelX Ltd.

What the filing shows about NewcelX Ltd.

  • 5 investors had already put money in when it filed.
  • The filing names 9 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on NewcelX Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Just raised? Your investors will ask for updates.

The weeks after a raise are when investors, other founders and press look NewcelX Ltd. up. FoxPlug is your startup's chief of staff: it reads your whole stack and tells you what to fix, what to say and what to skip, for founders shipping with Claude Code, Codex or Cursor. It drafts your monthly investor update from your real numbers, and its free tools need no account. GetFoxChat puts an AI operator on NewcelX Ltd.'s own site, named as you like, so the visitors this record sends you don't read one page and leave.

Who the filing names, and in what role

The filing gives NewcelX Ltd.'s address as Hohstrasse 1, Kloten, V8 8302.

What the filing says

  • Offered: $2,875,023. Sold: $2,875,023. Left to sell: nothing, all of it is sold. (filing)
  • Investors: 5 had already invested. (filing)
  • Date of first sale: November 9, 2026. (filing)
  • Types of securities: Equity; Options, warrants or other rights to acquire another security; Securities to be acquired on exercise of an option, warrant or other right; Other: Common shares and warrants to purchase common shares. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)
  • On the amounts offered and sold: the filing adds “Including the exercise price of common shares underlying such warrants at an exercise price of $3.75.” (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on NewcelX Ltd. See pricing

Is NewcelX Ltd. a real, registered company?

NewcelX Ltd. is a registered filer with the SEC (CIK 1783036) and has filed since 2022-10-14. 11 filings are on record, the latest on 2026-11-18.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs NewcelX Ltd.?

NewcelX Ltd.'s Form D of 2026-11-18 names Ronen Twito, Michel Revel, Kfir Molakandov and 6 more as its officers, directors or promoters.

How much has NewcelX Ltd. raised?

Its new offerings report $36.48M sold across 11 offerings, as its own filings state.

Filing history · 11 filings on this registrant
Form D · 2022-10-14 · $4MForm D · 2022-12-21 · $10MForm D · 2024-04-03 · $1.75MForm D · 2024-07-15 · $787KForm D · 2024-10-21 · $7.20MForm D · 2025-01-22 · $500KForm D · 2025-04-14 · $2MForm D · 2025-07-10 · $1MForm D · 2026-05-13 · $3.43MForm D · 2026-08-24 · $2.94MForm D · 2026-11-18 · $2.88M · this page 2022-10-14 2026-11-18

Each marker is one filing. The larger marker is the filing this page is about.

Biotechnology · by week
This raise, $2.88M, filed week of Nov 16

Trailing twelve months. 758 filings in Biotechnology, totalled by week. The dot is this raise, $2.88M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on NewcelX Ltd.?

What the filing shows about NewcelX Ltd.

  • 5 investors had already put money in when it filed.
  • The filing names 9 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)

A Full Report on NewcelX Ltd.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on NewcelX Ltd. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    1 cited source found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for NewcelX Ltd.. With no account yet, you sign up free and land on the result.

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

NewcelX Ltd.: Raised $2.88M, Form D filed 2026-11-18
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/newcelx-ltd-form-d-121840
Last updated 2026-11-19
Primary record: SEC filing 1 · SEC filing 2
NewcelX Ltd. raised $2.88M — SEC Form D filing, November 2026. MentionFox, 2026-11-19. https://mentionfox.com/funding/newcelx-ltd-form-d-121840